(1)
Hegg, R.; Mattar, A.; Matos-Neto, J. N. de; Pedrini, J. L.; Aleixo, S. B.; Rocha, R. O.; Cramer-Junior, R. P.; van-Eyll-Rocha, S. A Phase III, Randomized, Non-Inferiority Study Comparing the Efficacy and Safety of Biosimilar Filgrastim Versus Originator Filgrastim for Chemotherapy-Induced Neutropenia in Breast Cancer Patients . Clinics 2016, 71, 586-592.